Global Viral Vector Market Size study & Forecast, by Vector Type (Adeno-associated Virus (AAV), Adenovirus, Lentivirus, Retrovirus, Others), by Application (Cell & Gene Therapy, Vaccine, Biopharmaceutical & Pharmaceutical Discovery), by End User (Pharmaceutical & Biotechnology Companies, Academics & Research Institutes, CROs & CMOs) and Regional Analysis, 2023-2030
Global Viral Vector Market is valued at approximately USD 3.10 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 11.5% over the forecast period 2023-2030. A viral vector is a type of tool commonly used in molecular biology and genetic engineering to introduce genetic material into cells. It is constructed using a modified virus that has been rendered harmless for human or animal use and retains the ability to infect cells and deliver its genetic cargo. The Viral Vector Market is expanding because of factors such as increasing demand for gene therapies and rising investments in research and development with immense funding support.
The demand for viral vectors is predicted to increase as genetic abnormalities and infectious diseases become more common. For instance, according to data from the Joint United Nations Programme on HIV/AIDS (UNAIDS), around 38.4 million people had HIV in 2021, and by the end of the year, 28.7 million of those individuals had received antiretroviral therapy. Thus, the market is expanding. Furthermore, the amount of gene therapy research has substantially expanded as a result of the broad acceptance of viral vector medicines, many of which are currently undergoing advanced stages of clinical testing. Retroviral, adenoviral, adeno-associated viral, and lentiviral-based vectors are significant contemporary research and clinical trial candidates. For instance, according to the National Centre for Biotechnology Information, 137 adeno-associated viral-based therapies were in various phases of clinical development. Furthermore, most clinical trials were in their initial stages; nevertheless. 7.7% of them had already advanced to phase III. Along with these, in year 2021, the UK government announced that USD 339 million were invested into the life sciences industry. The USD 78 million dedicated to expanding manufacturing services will support cell and gene therapies, medical devices, and commercial scale production investments by various companies. Thus, rising gene therapy clinical trial activities are fostering market growth. In addition, advancements in genome sequencing and an increased amount of research in this area of gene therapy are creating a lucrative growth opportunity for the market. However, complex manufacturing processes, regulatory challenges, and intellectual property issues stifle market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Viral Vector Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market players and the region's increasing disease prevalence, and the rising number of clinical trial activities in the region. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising disease prevalence, rising government funding for gene therapeutics development, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government organizations in the market space.
Major market player included in this report are:
Oxford Biomedica
Lonza
Thermo Fisher Scientific Inc
Batavia Biosciences B.V.
Biogen
Spark Therapeutics, Inc.
Regenxbio Inc.
uniQURE N.V.
Asklepios BioPharmaceutical, Inc. (AskBio)
Sanofi
Recent Developments in the Market:
In January 2023, Forecyte Bio, a CDMO that deals with cell and gene therapies, built a new GMP facility to speed up the manufacture of viral vectors, cell therapies, and other goods. Additionally, the building would be about 17,000 square feet in size and include separate cleanrooms for each function.
Global Viral Vector Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Vector Type, Application, End User Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Vector Typeofferings of key players. The detailed segments and sub-segment of the market are explained below:
By Vector Type:
Adeno-associated Virus (AAV)
Adenovirus
Lentivirus
Retrovirus
Others
By Application:
Cell & Gene Therapy
Vaccine
Biopharmaceutical & Pharmaceutical Discovery
By End User:
Pharmaceutical & Biotechnology Companies
Academics & Research Institutes
CROs & CMOs
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
The demand for viral vectors is predicted to increase as genetic abnormalities and infectious diseases become more common. For instance, according to data from the Joint United Nations Programme on HIV/AIDS (UNAIDS), around 38.4 million people had HIV in 2021, and by the end of the year, 28.7 million of those individuals had received antiretroviral therapy. Thus, the market is expanding. Furthermore, the amount of gene therapy research has substantially expanded as a result of the broad acceptance of viral vector medicines, many of which are currently undergoing advanced stages of clinical testing. Retroviral, adenoviral, adeno-associated viral, and lentiviral-based vectors are significant contemporary research and clinical trial candidates. For instance, according to the National Centre for Biotechnology Information, 137 adeno-associated viral-based therapies were in various phases of clinical development. Furthermore, most clinical trials were in their initial stages; nevertheless. 7.7% of them had already advanced to phase III. Along with these, in year 2021, the UK government announced that USD 339 million were invested into the life sciences industry. The USD 78 million dedicated to expanding manufacturing services will support cell and gene therapies, medical devices, and commercial scale production investments by various companies. Thus, rising gene therapy clinical trial activities are fostering market growth. In addition, advancements in genome sequencing and an increased amount of research in this area of gene therapy are creating a lucrative growth opportunity for the market. However, complex manufacturing processes, regulatory challenges, and intellectual property issues stifle market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Viral Vector Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market players and the region's increasing disease prevalence, and the rising number of clinical trial activities in the region. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising disease prevalence, rising government funding for gene therapeutics development, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government organizations in the market space.
Major market player included in this report are:
Oxford Biomedica
Lonza
Thermo Fisher Scientific Inc
Batavia Biosciences B.V.
Biogen
Spark Therapeutics, Inc.
Regenxbio Inc.
uniQURE N.V.
Asklepios BioPharmaceutical, Inc. (AskBio)
Sanofi
Recent Developments in the Market:
In January 2023, Forecyte Bio, a CDMO that deals with cell and gene therapies, built a new GMP facility to speed up the manufacture of viral vectors, cell therapies, and other goods. Additionally, the building would be about 17,000 square feet in size and include separate cleanrooms for each function.
Global Viral Vector Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Vector Type, Application, End User Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Vector Typeofferings of key players. The detailed segments and sub-segment of the market are explained below:
By Vector Type:
Adeno-associated Virus (AAV)
Adenovirus
Lentivirus
Retrovirus
Others
By Application:
Cell & Gene Therapy
Vaccine
Biopharmaceutical & Pharmaceutical Discovery
By End User:
Pharmaceutical & Biotechnology Companies
Academics & Research Institutes
CROs & CMOs
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Viral Vector Market, by Region, 2020-2030 (USD Billion)
1.2.2. Viral Vector Market, by Vector Type, 2020-2030 (USD Billion)
1.2.3. Viral Vector Market, by Application, 2020-2030 (USD Billion)
1.2.4. Viral Vector Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL VIRAL VECTOR MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL VIRAL VECTOR MARKET DYNAMICS
3.1. Viral Vector Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing demand for gene therapies
3.1.1.2. Rising investments in research and development with immense funding support
3.1.2. Market Challenges
3.1.2.1. Complex manufacturing process.
3.1.2.2. Regulatory challenges and intellectual property issues.
3.1.3. Market Opportunities
3.1.3.1. Advancements in genome sequencing
3.1.3.2. Increased the amount of research in this area of gene therapy.
CHAPTER 4. GLOBAL VIRAL VECTOR MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL VIRAL VECTOR MARKET, BY VECTOR TYPE
5.1. Market Snapshot
5.2. Global Viral Vector Market by Vector Type, Performance - Potential Analysis
5.3. Global Viral Vector Market Estimates & Forecasts by Vector Type 2020-2030 (USD Billion)
5.4. Viral Vector Market, Sub Segment Analysis
5.4.1. Adeno-associated Virus (AAV)
5.4.2. Adenovirus
5.4.3. Lentivirus
5.4.4. Retrovirus
5.4.5. Others
CHAPTER 6. GLOBAL VIRAL VECTOR MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Viral Vector Market by Application, Performance - Potential Analysis
6.3. Global Viral Vector Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Viral Vector Market, Sub Segment Analysis
6.4.1. Cell & Gene Therapy
6.4.2. Vaccine
6.4.3. Biopharmaceutical & Pharmaceutical Discovery
CHAPTER 7. GLOBAL VIRAL VECTOR MARKET, BY END USER
7.1. Market Snapshot
7.2. Global Viral Vector Market by End User, Performance - Potential Analysis
7.3. Global Viral Vector Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
7.4. Viral Vector Market, Sub Segment Analysis
7.4.1. Pharmaceutical & Biotechnology Companies
7.4.2. Academics & Research Institutes
7.4.3. CROs & CMOs
CHAPTER 8. GLOBAL VIRAL VECTOR MARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Viral Vector Market, Regional Market Snapshot
8.4. North America Viral Vector Market
8.4.1. U.S. Viral Vector Market
8.4.1.1. Vector Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Viral Vector Market
8.5. Europe Viral Vector Market Snapshot
8.5.1. U.K. Viral Vector Market
8.5.2. Germany Viral Vector Market
8.5.3. France Viral Vector Market
8.5.4. Spain Viral Vector Market
8.5.5. Italy Viral Vector Market
8.5.6. Rest of Europe Viral Vector Market
8.6. Asia-Pacific Viral Vector Market Snapshot
8.6.1. China Viral Vector Market
8.6.2. India Viral Vector Market
8.6.3. Japan Viral Vector Market
8.6.4. Australia Viral Vector Market
8.6.5. South Korea Viral Vector Market
8.6.6. Rest of Asia Pacific Viral Vector Market
8.7. Latin America Viral Vector Market Snapshot
8.7.1. Brazil Viral Vector Market
8.7.2. Mexico Viral Vector Market
8.8. Middle East & Africa Viral Vector Market
8.8.1. Saudi Arabia Viral Vector Market
8.8.2. South Africa Viral Vector Market
8.8.3. Rest of Middle East & Africa Viral Vector Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Oxford Biomedica
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Lonza
9.3.3. Thermo Fisher Scientific Inc
9.3.4. Batavia Biosciences B.V.
9.3.5. Biogen
9.3.6. Spark Therapeutics, Inc.
9.3.7. Regenxbio Inc.
9.3.8. uniQURE N.V.
9.3.9. Asklepios BioPharmaceutical, Inc. (AskBio)
9.3.10. Sanofi
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Viral Vector Market, by Region, 2020-2030 (USD Billion)
1.2.2. Viral Vector Market, by Vector Type, 2020-2030 (USD Billion)
1.2.3. Viral Vector Market, by Application, 2020-2030 (USD Billion)
1.2.4. Viral Vector Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL VIRAL VECTOR MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL VIRAL VECTOR MARKET DYNAMICS
3.1. Viral Vector Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing demand for gene therapies
3.1.1.2. Rising investments in research and development with immense funding support
3.1.2. Market Challenges
3.1.2.1. Complex manufacturing process.
3.1.2.2. Regulatory challenges and intellectual property issues.
3.1.3. Market Opportunities
3.1.3.1. Advancements in genome sequencing
3.1.3.2. Increased the amount of research in this area of gene therapy.
CHAPTER 4. GLOBAL VIRAL VECTOR MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL VIRAL VECTOR MARKET, BY VECTOR TYPE
5.1. Market Snapshot
5.2. Global Viral Vector Market by Vector Type, Performance - Potential Analysis
5.3. Global Viral Vector Market Estimates & Forecasts by Vector Type 2020-2030 (USD Billion)
5.4. Viral Vector Market, Sub Segment Analysis
5.4.1. Adeno-associated Virus (AAV)
5.4.2. Adenovirus
5.4.3. Lentivirus
5.4.4. Retrovirus
5.4.5. Others
CHAPTER 6. GLOBAL VIRAL VECTOR MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Viral Vector Market by Application, Performance - Potential Analysis
6.3. Global Viral Vector Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Viral Vector Market, Sub Segment Analysis
6.4.1. Cell & Gene Therapy
6.4.2. Vaccine
6.4.3. Biopharmaceutical & Pharmaceutical Discovery
CHAPTER 7. GLOBAL VIRAL VECTOR MARKET, BY END USER
7.1. Market Snapshot
7.2. Global Viral Vector Market by End User, Performance - Potential Analysis
7.3. Global Viral Vector Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
7.4. Viral Vector Market, Sub Segment Analysis
7.4.1. Pharmaceutical & Biotechnology Companies
7.4.2. Academics & Research Institutes
7.4.3. CROs & CMOs
CHAPTER 8. GLOBAL VIRAL VECTOR MARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Viral Vector Market, Regional Market Snapshot
8.4. North America Viral Vector Market
8.4.1. U.S. Viral Vector Market
8.4.1.1. Vector Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Viral Vector Market
8.5. Europe Viral Vector Market Snapshot
8.5.1. U.K. Viral Vector Market
8.5.2. Germany Viral Vector Market
8.5.3. France Viral Vector Market
8.5.4. Spain Viral Vector Market
8.5.5. Italy Viral Vector Market
8.5.6. Rest of Europe Viral Vector Market
8.6. Asia-Pacific Viral Vector Market Snapshot
8.6.1. China Viral Vector Market
8.6.2. India Viral Vector Market
8.6.3. Japan Viral Vector Market
8.6.4. Australia Viral Vector Market
8.6.5. South Korea Viral Vector Market
8.6.6. Rest of Asia Pacific Viral Vector Market
8.7. Latin America Viral Vector Market Snapshot
8.7.1. Brazil Viral Vector Market
8.7.2. Mexico Viral Vector Market
8.8. Middle East & Africa Viral Vector Market
8.8.1. Saudi Arabia Viral Vector Market
8.8.2. South Africa Viral Vector Market
8.8.3. Rest of Middle East & Africa Viral Vector Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Oxford Biomedica
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Lonza
9.3.3. Thermo Fisher Scientific Inc
9.3.4. Batavia Biosciences B.V.
9.3.5. Biogen
9.3.6. Spark Therapeutics, Inc.
9.3.7. Regenxbio Inc.
9.3.8. uniQURE N.V.
9.3.9. Asklepios BioPharmaceutical, Inc. (AskBio)
9.3.10. Sanofi
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Viral Vector Market, report scope
TABLE 2. Global Viral Vector Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Viral Vector Market estimates & forecasts by Vector Type 2020-2030 (USD Billion)
TABLE 4. Global Viral Vector Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Viral Vector Market estimates & forecasts by End User 2020-2030 (USD Billion)
TABLE 6. rGlobal Viral Vector Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Viral Vector Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Viral Vector Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Viral Vector Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Viral Vector Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Viral Vector Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Viral Vector Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Viral Vector Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Viral Vector Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Viral Vector Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Viral Vector Market
TABLE 71. List of primary sources, used in the study of global Viral Vector Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Viral Vector Market, report scope
TABLE 2. Global Viral Vector Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Viral Vector Market estimates & forecasts by Vector Type 2020-2030 (USD Billion)
TABLE 4. Global Viral Vector Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Viral Vector Market estimates & forecasts by End User 2020-2030 (USD Billion)
TABLE 6. rGlobal Viral Vector Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Viral Vector Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Viral Vector Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Viral Vector Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Viral Vector Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Viral Vector Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Viral Vector Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Viral Vector Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Viral Vector Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Viral Vector Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Viral Vector Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Viral Vector Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Viral Vector Market
TABLE 71. List of primary sources, used in the study of global Viral Vector Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Viral Vector Market, research methodology
FIG 2. Global Viral Vector Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Viral Vector Market, key trends 2022
FIG 5. Global Viral Vector Market, growth prospects 2023-2030
FIG 6. Global Viral Vector Market, porters 5 force model
FIG 7. Global Viral Vector Market, pest analysis
FIG 8. Global Viral Vector Market, value chain analysis
FIG 9. Global Viral Vector Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Viral Vector Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Viral Vector Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Viral Vector Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Viral Vector Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Viral Vector Market, regional snapshot 2020 & 2030
FIG 15. North America Viral Vector Market 2020 & 2030 (USD Billion)
FIG 16. Europe Viral Vector Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Viral Vector Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Viral Vector Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Viral Vector Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Viral Vector Market, research methodology
FIG 2. Global Viral Vector Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Viral Vector Market, key trends 2022
FIG 5. Global Viral Vector Market, growth prospects 2023-2030
FIG 6. Global Viral Vector Market, porters 5 force model
FIG 7. Global Viral Vector Market, pest analysis
FIG 8. Global Viral Vector Market, value chain analysis
FIG 9. Global Viral Vector Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Viral Vector Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Viral Vector Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Viral Vector Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Viral Vector Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Viral Vector Market, regional snapshot 2020 & 2030
FIG 15. North America Viral Vector Market 2020 & 2030 (USD Billion)
FIG 16. Europe Viral Vector Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Viral Vector Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Viral Vector Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Viral Vector Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
